Literature DB >> 35317436

Diabetes mellitus: Plasticizers and nanomaterials acting as endocrine-disrupting chemicals (Review).

Mihaela Jana Tuculina1, Paula Perlea2, Mircea Gheorghiță1, Cristian Niky Cumpătă3, Ionela Teodora Dascălu1, Adina Turcu1, Andreea Gabriela Nicola1, Lelia Mihaela Gheorghiță1, Oana Andreea Diaconu1, Ana Valea4, Adina Ghemigian5,6, Mara Carsote5,6.   

Abstract

Various plasticizers and nanomaterials have been linked to endocrine disruptors or endocrine-disrupting chemicals (EDCs) which represent a large, heterogeneous, yet incompletely understood group of structures acting on normal and pathological body pathways such as hormonal production, secretion, transport and receptor binding. By contrast, various applications of nanoparticles are currently under investigation since the delivery of useful drugs, particularly insulin in diabetes mellitus, is essential in case of insulin deficiency. The aim of the present review was to introduce and examine different plasticizers and nanomaterials with potential applications for diabetic patients (such as selenium or gold-based nanoparticles that help the oral delivery of insulin) or plasticizers/nanomaterials acting similarly to EDCs in relation to the human and animal body, particularly glucose metabolism impairment such as diabetes mellitus (DM). Bisphenol A is a chemical used worldwide; however, the effect of exposure varies with regard to the source, environment, time of exposure and the age of the organism. Daily exposure is mostly related to food and drinks stored in polycarbonate plastics. However, exposure may also be through the skin or through the maternal placenta or breast milk which are risk factors for the fetus and for the newborn. It exerts an estrogen-like profile, but it also induces insulin resistance by impairing peripheral insulin receptors or it decreases insulin secretion by acting at the level of insulin-secreting pancreatic β-cells. Phthalates, compounds of flexible plastics, act as EDCs via their human metabolites such as diethyl phthalate and derivative monoethyl phthalate. Their role in inducing gestational DM and weight gain/obesity during pregnancy has been showcased. The vast field of plasticizers and nanomolecules acting as endocrine disruptors is widely linked to clinical aspects of DM, a serious condition with a major population impact. The importance of understanding and using these agents and applications is reflected in saving numerous human lives.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  bisphenol A; diabetes mellitus; endocrine disruptors; nanomaterial; phthalates; plasticizers

Year:  2022        PMID: 35317436      PMCID: PMC8908456          DOI: 10.3892/etm.2022.11217

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  48 in total

1.  Sub-chronic palladium nanoparticle effects on the endocrine reproductive system of female Wistar rats: Preliminary data.

Authors:  Veruscka Leso; Luca Fontana; Alessandro Marinaccio; Kerstin Leopold; Caterina Fanali; Donatella Lucchetti; Alessandro Sgambato; Ivo Iavicoli
Journal:  Toxicol Ind Health       Date:  2019-05-26       Impact factor: 2.273

2.  Association of bisphenol A exposure with overweight in the elderly: a panel study.

Authors:  Mee-Ri Lee; Jin Hee Kim; Yoon-Hyeong Choi; Sanghyuk Bae; Choonghee Park; Yun-Chul Hong
Journal:  Environ Sci Pollut Res Int       Date:  2015-01-21       Impact factor: 4.223

3.  Modified apple polysaccharide capped gold nanoparticles for oral delivery of insulin.

Authors:  Yogita Kumari; Sachin Kumar Singh; Rajesh Kumar; Bimlesh Kumar; Gurmandeep Kaur; Monica Gulati; Devesh Tewari; K Gowthamarajan; V V S Narayana Reddy Karri; Clarisse Ayinkamiye; Rubiya Khursheed; Ankit Awasthi; Narendra Kumar Pandey; Souvik Mohanta; Saurabh Gupta; Leander Corrie; Pooja Patni; Rajan Kumar; Rakesh Kumar
Journal:  Int J Biol Macromol       Date:  2020-02-01       Impact factor: 6.953

4.  Selenium nanoparticles as versatile carriers for oral delivery of insulin: Insight into the synergic antidiabetic effect and mechanism.

Authors:  Wenji Deng; Qian Xie; Huan Wang; Zhiguo Ma; Baojian Wu; Xingwang Zhang
Journal:  Nanomedicine       Date:  2017-05-21       Impact factor: 5.307

5.  Exposure to bisphenol A and diabetes risk in Mexican women.

Authors:  Luke Murphy; Ángel Mérida-Ortega; Mariano E Cebrián; Lucia Hernández-Garciadiego; Humberto Gómez-Ruiz; Brenda Gamboa-Loira; Lizbeth López-Carrillo
Journal:  Environ Sci Pollut Res Int       Date:  2019-07-09       Impact factor: 4.223

Review 6.  Endocrine-disrupting chemicals and behaviour: A high risk to take?

Authors:  Ioannis Bakoyiannis; Efthymia Kitraki; Antonios Stamatakis
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2021-03-10       Impact factor: 4.690

Review 7.  Endocrine Disruptors and the Induction of Insulin Resistance.

Authors:  Rafael Vanni; Renata Maksoud Bussuan; Renato Luiz Rombaldi; Alberto K Arbex
Journal:  Curr Diabetes Rev       Date:  2021

Review 8.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

Review 9.  Endocrine-Disrupting Chemicals' (EDCs) Effects on Tumour Microenvironment and Cancer Progression: Emerging Contribution of RACK1.

Authors:  Erica Buoso; Mirco Masi; Marco Racchi; Emanuela Corsini
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

10.  Anti-hyperglycemic activity of selenium nanoparticles in streptozotocin-induced diabetic rats.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Ahmed Esmat Abdel Moneim
Journal:  Int J Nanomedicine       Date:  2015-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.